11.05.2020
Rapid Nutrition PLC (OTCQB: RPNRF, SW: RAP), a natural healthcare company focused on sports nutrition, diet management and life sciences products with extensive worldwide distribution, is expanding its focus on the U.S. capital markets.
10.01.2020
Rapid Nutrition PLC (SW:RAP, OTCQB:RPNRF), a natural wellness company focused on organic wholefood-based nutrition and science-based herbal products, announced the following trading update ahead of the publication
08.12.2020
The Australian government has accepted Rapid Nutrition ( RAP: SW, OTCQB: RPNRF ) into its touted Entrepreneurs Programme, which shares expert advice, funding and incentives to help businesses innovate, compete and grow.
06.10.2020
Following its recent announcement of a new treatment designed to help relieve symptoms of cold and flu, Rapid Nutrition (RAP:SW, OTCQB:RPNRF) has been awarded an Innovation Connections grant to further develop and commercialize the formula. Sponsored by the Australian government
06.02.2020
With a focus on international growth by further enhancing its product portfolio through new acquisitions, licensing, joint venture arrangements for its expanding distribution pipeline, Rapid Nutrition recently released a market update for investors and shareholders.
04.28.2020
As the sales of wellness products continues to skyrocket, Rapid Nutrition is expanding global distribution through a new partnership with Cloud 9 Switzerland LLC. The agreement will support distribution of Rapid Nutrition’s flagship brand, SystemLS, throughout France, Italy, Switzerland, Jamaica and CARICOM.
04.08.2020
Expanding its online and in-store footprint to South America, Rapid Nutrition ( RAP:SW, OTCQB: RPNRF) has announced a new partnership to distribute its flagship brand, SystemLS
03.30.2020
Rapid Nutrition, a natural healthcare company focused on the research and development, manufacture and distribution of weight-loss and diet management products, sports nutrition products, vitamins and dietary supplements, and a range of life science products, is pleased to announce its H1 results.
02.03.2020
The Company announces that with reference to its media announcement of 9 January 2020, valid conversion notices from Investors and Management* have been received in respect of 4,474,867 New Shares. Following the conversion, the total number of shares in issue is 38'849'541.
01.16.2020
Rapid Nutrition plc CEO, Simon St Ledger featured on OTCQB's first podcast for 2020.
01.14.2020
Rapid Nutrition Plc (RAP:SW, OTCQB: RPNRF), a natural healthcare company focused on the research, development and production of a range of life science products, is pleased to announce a trading update for the six months ended 31 December 2019.
01.09.2020
The Company announces that valid conversion notices from Investors have been received in respect of 4,474,867 new shares. Following the conversion, the total number of shares in issue is 38,849,541.
01.07.2020
Rapid Nutrition PLC (RAP:SW, OTCQB: RPNRF), a natural healthcare company focused on the research, development and production of a range of life science products.
12.20.2019
LONDON UK, - Rapid Nutrition PLC (RAP:SW, OTCQB: RPNRF)("Company"), a natural healthcare company focused on the research, development and production of a range of life science products, today announced that Argus Research Co. ("Argus") has published their update Equity Report coverage on the Company.
12.05.2019
Rapid Nutrition PLC (SWX: RAP, OTC:RPNRF), a UK natural healthcare company focused on the research and development, manufacturing and distribution, is pleased to announce that at its Annual General Meeting held yesterday,
12.04.2019
Rapid Nutrition (SW: RAP, OTC: RPNRF), a natural healthcare company focused on the research and development ("R&D"), manufacturing and distribution of weight-loss and diet management products
11.29.2019
Rapid Nutrition PLC, (RAP:SW, OTCQB:RPNRF) (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, today announced it has completed a non-brokered placement of €240,000
11.02.2019
Rapid Nutrition ((RAP:SW, OTCQB: RPNRF), a natural healthcare company focused on the research, development and production of a range of life science products, is pleased to announce its audited results for the year ended 30 June 2019.
10.10.2019
Rapid Nutrition PLC (RAP:SW/OTCQB: RPNRF), based in UK, focused on the research, development and production of a range of life science products, today announced that Simon St Ledger, CEO, will present live at VirtualInvestorConferences.com on October 10th.
10.03.2019
Rapid Nutrition PLC (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, provided today an update to shareholders focusing on operational results in advance of its fiscal year-end for 2019.
09.30.2019
Rapid Nutrition PLC (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, today provided an update on its distribution agreement with international distribution company Super Health Center
09.19.2019
Rapid Nutrition PLC (RAP:SW, OTCQB: RPNRF)(“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, today announced that it intends to apply for submission to trade on the OTCQX® Best Market.
09.11.2019
Rapid Nutrition PLC (RAP:SW/OTCQB: RPNRF)(“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, today announced that Argus Research Co. (“Argus”) has initiated Equity Report coverage on the Company.
08.14.2019
Rapid Nutrition PLC(“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, announced today it has further expanded its distribution network partnering with Australia’s largest natural health retailer, Mr. Vitamins.
07.24.2019
Rapid Nutrition PLC (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, announced today it has expanded its distribution partnering with ASX listed pharmaceutical company Sigma Healthcare to launch health and wellness giant GNC further across the Australian pharmacy network.
07.23.2019
The Company announces with reference to its media announcement of 14 June 2019, valid conversion notices from Investors have been received in respect of 1,914,850 new shares.
07.09.2019
Rapid Nutrition PLC (SWX: RAP, OTCQB: RPNRF)(“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, is pleased to announce that it has successfully obtained Clearing and Depository Services ("CDS") eligibility in North America.
06.18.2019
Rapid Nutrition PLC (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, announced today it has signed an agreement with international distribution company Super Health Center
06.14.2019
Switzerland – The Company announces that valid conversion notices from Investors have been received in respect of 1,914,850 new shares. Following the conversion, the total number of share in issue is 34,374,674.
05.21.2019
Rapid Nutrition PLC (SWX: RAP, OTCQB: RPNRF) ("Company"), a natural healthcare company focused on the research, development and production of a range of life science products, announced today, veteran sales leader, Doug Kuskopf-Dallas will join the Company as Vice President of Sales in Australia.
Subscribe for Updates